Stocks

Nyxoah Secures European Approval For Genio 2.1 Neurostimulation Therapy For Sleep Apnea

ByVandana Singh

Jul 19, 2022
Nyxoah Secures European Approval For Genio 2.1 Neurostimulation Therapy For Sleep Apnea

[ad_1]

  • The DEKRA Notified Body has approved the use of Nyxoah SA’s NYXH next-generation Genio 2.1 system for patients in Europe. 

  • Genio 2.1 is a patient-centered, leadless, and battery-free hypoglossal neurostimulation therapy for Obstructive Sleep Apnea.

  • As with the recent approval of Genio 2.1 by the FDA for use in the DREAM U.S. IDE pivotal study, this CE mark pertains entirely to the external components of the Genio system. 

  • Related: FDA Signs Off Nyxoah’s Genio Trial In Complete Concentric Collapse Patients.

  • It will be available to all patients who have received Genio implants.

  • Genio 2.1 is designed to improve patient comfort and compliance with a new smartphone application and upgraded external activation chip. 

  • Genio 2.1 offers patients daily feedback on therapy usage and the autonomy to adjust stimulation amplitude within pre-defined boundaries. 

  • Physicians can fine-tune stimulation amplitude to determine the optimal comfort level for patients without compromising therapy efficacy. 

  • Additional embedded sensors will allow physicians to further tailor therapy stimulation parameters based on patient position and throughout the night. 

  • Price Action: NYXH shares closed 1.69% higher at $9.00 on Monday.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[ad_2]

Image and article originally from www.benzinga.com. Read the original article here.

By Vandana Singh

Related Post

Stocks

Looking At Netflix’s Recent Whale Trades

Aug 16, 2022 Benzinga Insights
Stocks

Generac Grid Services Bags Multi-Year Contract From Arizona Public Service

Aug 16, 2022 Akanksha Bakshi
Stocks

Despite Lower Equipment Demand In The Cannabis Market urban-gro Q2 Revenue Grows Thanks To This

Aug 16, 2022 Vuk Zdinjak

You missed

Crypto

Psychedelic Acquisition: Psycheceutical To Buy Majority Equity Stake In Maryland R&D Company

Aug 16, 2022 Lara Goldstein
Commodities

6 Shocking Charts Show the Future for Inflation & US Dollar

Aug 16, 2022 admin
Forex

Housing Starts Plunged, But Home Depot Turned In A Record Quarter: How The Home Improvement Retailer Is Defying Housing Market Trends

Aug 16, 2022 Adam Eckert
Investing

Alibaba Group Holding Whale Trades For August 16

Aug 16, 2022 Benzinga Insights